Yao Zhang

发表论文 2 篇 · 总被引 18 次 · h-index 2

代表论文

• Obinutuzumab is effective for the treatment of rituximab-refractory PLA2R-associated membranous nephropathy (2025 · Clinical Kidney Journal · 被引 13)
• Case report: One case of refractory membranous nephropathy with hypokalemia after rituximab infusion was switched to obinutuzumab without recurrence of hypokalemia (2024 · Frontiers in Pharmacology · 被引 13)